MRK Expands Vaccine Approval
Merck announces FDA approval of an expanded indication for its pneumococcal vaccine CAPVAXIVE
Merck announces FDA approval of an expanded indication for its pneumococcal vaccine CAPVAXIVE
Merck announces FDA approval of an expanded indication for its pneumococcal vaccine CAPVAXIVE
Merck announces FDA approval of an expanded indication for its pneumococcal vaccine CAPVAXIVE